The Biologics Price Competition and Innovation Act of 2009 would spur the development of products intended to be biosimilar to approved therapies
Rheumatology Drug Updates
Information on new approvals and medication safety that rheumatologists need to know
ACR/ARHP Annual Meeting 2012: Immunosuppressed Rheumatic Disease Patients Still Candidates for Vaccines
People with rheumatic diseases can be considered to receive flu and pneumococcal vaccines even if they’re on immunosuppressive drugs
Rheumatology Drug Updates
Information on new approvals and medication safety rheumatologists need to know
A&R Abstracts: Methotrexate
For further reading
Old Drugs Can Learn New Tricks
Methotrexate and its mechanism of action
FDA Seeks Comments on Drug Shortages
As reported last month (“Rheumatologists Struggle with Drug Shortages,” October 2011, p. 51), a bill (S. 296) proposed in the U.S. Senate would require drug manufacturers to notify the U.S. Food and Drug Administration (FDA) of factors that might lead to a drug shortage.
Clinical Trials Go Global
As medical research expands to the global population, will trial results sill apply to U.S. populations?
Drug Updates
Information on new approvals and medication safety
Rheumatologists Struggle with Drug Shortages
While not yet at a ‘catastrophic’ level, shortages are becoming more common
- « Previous Page
- 1
- …
- 5
- 6
- 7
- 8
- 9
- 10
- Next Page »